In 2025, AstraZeneca spent over ** billion U.S. dollars on research and development. AstraZeneca plc is one of the major pharmaceutical companies worldwide (based on Rx drug revenue). The multinational company is headquartered in London, UK. AstraZeneca is focused on products for the following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. Together with Oxford University, the company also developed one of the first effective COVID-19 vaccines.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
AstraZeneca, & U.S. Securities and Exchange Commission. (February 18, 2026). Research and development expenditure of AstraZeneca from 2006 to 2025 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 21, 2026, from /statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/
AstraZeneca, und U.S. Securities and Exchange Commission. "Research and development expenditure of AstraZeneca from 2006 to 2025 (in million U.S. dollars)." Chart. February 18, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 21, 2026. /statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/
AstraZeneca, U.S. Securities and Exchange Commission. (2026). Research and development expenditure of AstraZeneca from 2006 to 2025 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 21, 2026. /statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/
AstraZeneca, and U.S. Securities and Exchange Commission. "Research and Development Expenditure of Astrazeneca from 2006 to 2025 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 18 Feb 2026, /statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/
AstraZeneca & U.S. Securities and Exchange Commission, Research and development expenditure of AstraZeneca from 2006 to 2025 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/ (last visited July 21, 2026)
Research and development expenditure of AstraZeneca from 2006 to 2025 (in million U.S. dollars) [Graph], AstraZeneca, & U.S. Securities and Exchange Commission, February 18, 2026. [Online]. Available: /statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/
